Detailed Information on Publication Record
2021
4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
BRYJA, Vítězslav, Pavlína JANOVSKÁ, Michaela GREGOROVÁ, Václav NĚMEC, PrashantKumar KHIRSARIYA et. al.Basic information
Original name
4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Authors
BRYJA, Vítězslav (203 Czech Republic, belonging to the institution), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), Michaela GREGOROVÁ (203 Czech Republic, belonging to the institution), Václav NĚMEC (203 Czech Republic, belonging to the institution), PrashantKumar KHIRSARIYA (356 India, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution)
Edition
Number: AU 2019246220, Publisher: The Australian Patents Register, Place of publication: Australia, Owner's name: Masarykova univerzita, 2021
Other information
Language
English
Type of outcome
Patent
Field of Study
10401 Organic chemistry
Country of publisher
Australia
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14310/21:00121220
Organization unit
Faculty of Science
Keywords in English
lymphomas; leukaemia; solid tumors
Změněno: 11/3/2021 16:13, Mgr. Marie Šípková, DiS.
Abstract
V originále
The present invention relates to novel heterocyclic compounds useful in the treatment of leukaemias, lymphomas and solid tumors.
Links
| EF16_025/0007381, research and development project |
| ||
| LM2018130, research and development project |
|